Patents by Inventor Tobias Schoep

Tobias Schoep has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220267636
    Abstract: Described herein is a method of manufacturing a one-pack polyurethane dispersion, where the dispersion includes a polyurethane containing hydroxyl groups and at least one group selected from the group consisting of acid groups and polyalkoxylene groups, the acid groups of the polyurethane, if present, being neutralized to an extent from 0 to 100 mol-% of the acid groups; and a fully blocked polyisocyanate; where the method includes obtaining a mixture A; reacting a hydroxy-functional polymer with mixture A, thus-obtaining a mixture B; and neutralizing 0 to 100 mol-% of the acid groups, if contained in mixture B, based on the total amount of acid groups in mixture B. Also described herein are one-pack polyurethane dispersions obtainable according to the method, one-pack coating materials including the same and coated substrates including cured coating materials.
    Type: Application
    Filed: July 15, 2020
    Publication date: August 25, 2022
    Inventors: Tobias Schoepping, Sylvia Zihang, Beate Podlaski-Pyzik, Kerstin Sperber
  • Patent number: 8992935
    Abstract: The present invention relates to a means of controlling infection persistence of Helicobacter pylori (H. pylori). In particular, the present invention relates to an isolated, genetically modified Helicobacter pylori comprising a functional urease, wherein the contiguous amino acid sequence between amino acid 529 and amino acid 555 of SEQ ID NO:1 is altered to produce said modified Helicobacter pylori which is unable to establish or maintain a persistent infection.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: March 31, 2015
    Assignee: Ondek Pty. Ltd.
    Inventors: Mohammed Benghezal, Tobias Schoep, Alma Fulurija, Douglas E. Berg, Barry J. Marshall
  • Publication number: 20130259888
    Abstract: The present invention relates to a means of controlling infection persistence of Helicobacter pylori (H. pylori). In particular, the present invention relates to an isolated, genetically modified Helicobacter pylori comprising a functional urease, wherein the contiguous amino acid sequence between amino acid 529 and amino acid 555 of SEQ ID NO:1 is altered to produce said modified Helicobacter pylori which is unable to establish or maintain a persistent infection.
    Type: Application
    Filed: June 24, 2011
    Publication date: October 3, 2013
    Applicant: ONDEK PTY LTD
    Inventors: Mohammed Benghezal, Tobias Schoep, Alma Fulurija, Douglas E. Berg, Barry J. Marshall